SCHEMBL29660237

SCHEMBL29660237

CCOC(=O)c1ccn2c(n1)nc1cc(Br)ccc12

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
CYP1A2 P05177 1/20 0.43
ADORA2B P29275 4/20 0.43
ELANE P08246 3/20 0.42
LMNA P02545 2/20 0.41
MAPT P10636 2/20 0.41
POLB P06746 2/20 0.41
NPC1 O15118 1/20 0.41
PKM P14618 1/20 0.41
RAB9A P51151 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
ATM Q13315 1/20 0.40
KDM4E B2RXH2 3/20 0.40
HPGD P15428 2/20 0.40
GABRA2 P47869 1/20 0.39
GABRB2 P47870 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18548712 1.00 ALDH1A1 (0.49) ALDH1A1SMN1; SMN2CYP1A2ADORA2BELANE
SCHEMBL18548610 0.91 ALDH1A1 (0.52) ALDH1A1SMN1; SMN2CYP1A2ADORA2BELANE
SCHEMBL27365441 0.86 DPP4 (0.48) ALDH1A1CYP1A2ADORA2BKDM4EHPGD
SCHEMBL29660209 0.85 KDM4E (0.46) ALDH1A1SMN1; SMN2CYP1A2ELANELMNA
SCHEMBL18548622 0.85 KDM4E (0.46) ALDH1A1SMN1; SMN2CYP1A2ELANELMNA
SCHEMBL29660200 0.83 CYP1A2 (0.51) ALDH1A1SMN1; SMN2CYP1A2MAPTNPC1
SCHEMBL18548710 0.83 CYP1A2 (0.51) ALDH1A1SMN1; SMN2CYP1A2MAPTNPC1
SCHEMBL29660262 0.81 MCL1 (0.39) ALDH1A1SMN1; SMN2KDM4E
SCHEMBL18548700 0.81 MCL1 (0.39) ALDH1A1SMN1; SMN2KDM4E
SCHEMBL18548688 0.78 KDM4E (0.49) ALDH1A1SMN1; SMN2CYP1A2ELANELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11344637-B2 Probes for imaging huntingtin protein CHDI FOUNDATION, INC. (US) 2022-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11344637-B2 Probes for imaging huntingtin protein HTT, HYPK, HSPBP1 ALDH1A1 3976/4885SMN1; SMN2 106/4885CYP1A2 4836/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.